(Q38078661)
Statements
1 reference
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). (English)
1 reference
Jan N Basile
1 reference
1 February 2013
1 reference
1 reference
Identifiers
1 reference